173 related articles for article (PubMed ID: 38509509)
1. GRADE-ADOLOPMENT of hyperthyroidism treatment guidelines for a Pakistani context.
Martins RS; Nadeem S; Aziz A; Raja S; Pervez A; Islam N; Ahmed A; Sheikh A; Furqan S; Ram N; Rizwan A; Rizvi NA; Mustafa MA; Aamdani SS; Ayub B; Masood MQ
BMC Endocr Disord; 2024 Mar; 24(1):41. PubMed ID: 38509509
[TBL] [Abstract][Full Text] [Related]
2. Adolopment of adult diabetes mellitus management guidelines for a Pakistani context: Methodology and challenges.
Martins RS; Masood MQ; Mahmud O; Rizvi NA; Sheikh A; Islam N; Khowaja ANA; Ram N; Furqan S; Mustafa MA; Aamdani SS; Pervez A; Haider AH; Nadeem S
Front Endocrinol (Lausanne); 2022; 13():1081361. PubMed ID: 36686436
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
[TBL] [Abstract][Full Text] [Related]
4. Update on Pediatric Hyperthyroidism.
Vaidyanathan P
Adv Pediatr; 2022 Aug; 69(1):219-229. PubMed ID: 35985711
[TBL] [Abstract][Full Text] [Related]
5. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
Kahaly GJ
J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
[TBL] [Abstract][Full Text] [Related]
6. GRADE-ADOLOPMENT of clinical practice guideline for postmenopausal osteoporosis management-a Pakistani context.
Nadeem S; Pervez A; Abid MA; Khalid RN; Rizvi NA; Aamdani SS; Ayub B; Mustafa MA; Ahmed S; Riaz M; Irfan K; Noordin S; Jafri L; Majid H; Umer M; Zehra N; Sheikh A; Haider AH; Khan AH
Arch Osteoporos; 2023 May; 18(1):71. PubMed ID: 37204537
[TBL] [Abstract][Full Text] [Related]
7. Hyperthyroidism.
De Leo S; Lee SY; Braverman LE
Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492
[TBL] [Abstract][Full Text] [Related]
8. Hyperthyroidism.
Chaker L; Cooper DS; Walsh JP; Peeters RP
Lancet; 2024 Feb; 403(10428):768-780. PubMed ID: 38278171
[TBL] [Abstract][Full Text] [Related]
9. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Bahn RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
Endocr Pract; 2011; 17(3):456-520. PubMed ID: 21700562
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
11. A 2011 survey of clinical practice patterns in the management of Graves' disease.
Burch HB; Burman KD; Cooper DS
J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
[TBL] [Abstract][Full Text] [Related]
12. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.
Ross DS; Burch HB; Cooper DS; Greenlee MC; Laurberg P; Maia AL; Rivkees SA; Samuels M; Sosa JA; Stan MN; Walter MA
Thyroid; 2016 Oct; 26(10):1343-1421. PubMed ID: 27521067
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
14. Chronology of Graves' ophthalmopathy in an incidence cohort.
Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
[TBL] [Abstract][Full Text] [Related]
15. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
Maia AL; Scheffel RS; Meyer EL; Mazeto GM; Carvalho GA; Graf H; Vaisman M; Maciel LM; Ramos HE; Tincani AJ; Andrada NC; Ward LS;
Arq Bras Endocrinol Metabol; 2013 Apr; 57(3):205-32. PubMed ID: 23681266
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
Okamura K; Bandai S; Fujikawa M; Sato K; Kitazono T
Endocr J; 2020 Jul; 67(7):751-758. PubMed ID: 32238669
[TBL] [Abstract][Full Text] [Related]
17. [Hyperthyroidism in the aged].
Real JT; Ascaso JF
Med Clin (Barc); 2002 Jun; 118(20):784-7. PubMed ID: 12049696
[No Abstract] [Full Text] [Related]
18. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Wiersinga WM; Poppe KG; Effraimidis G
Lancet Diabetes Endocrinol; 2023 Apr; 11(4):282-298. PubMed ID: 36848916
[TBL] [Abstract][Full Text] [Related]
19. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
20. Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.
Dunkelmann S; Wolf R; Koch A; Kittner C; Groth P; Schuemichen C
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1428-34. PubMed ID: 15221291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
